 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
at time of writing, Pharmacy Practice Resident, Saint Michael's Medical Center, Newark, NJ; now, Clinical Assistant Professor, Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ; Clinical Pharmacist, Mountainside Hospital, Montclair, NJ
Clinical Assistant Professor, School of Graduate Medical Education, Seton Hall University, South Orange, NJ; Director, Pharmacotherapy Education and Residency Programs, Saint Michael's Medical Center
Administrative Medical Educator, School of Graduate Medical Education, Seton Hall University; Associate Professor, Clinical Internal Medicine, College of Osteopathic Medicine, University of New England, Biddeford, ME
at time of writing, Director of Pharmacy, Saint Michael's Medical Center, Newark, NJ; now, Manager, Pharmacy Department, Overlook Hospital, Summit, NJ
Reprints: Dr. Chahine-Chakhtoura, Pharmacy Department, Saint Michael's Medical Center, 111 Central Ave., Newark, NJ 07102, fax 973/877-5577, corinnec{at}chhsnj.org
BACKGROUND: The impact of pharmacy residents' interventions on medical rounds has not been well evaluated.
OBJECTIVE: To assess the impact of a resident's interventions on hospital length of stay, describe the types of interventions, and assess drug-related cost savings.
METHODS: Using a matched control design, we conducted an evaluative study of adults admitted to a general internal medicine unit over one month. The study group consisted of patients admitted to the service of a medical team that included a pharmacy resident and medical residents. The pharmacy resident prospectively collected data on patient demographics and interventions made during patient admission and follow-up rounds. The control group consisted of patients admitted to the service of a team consisting of medical residents only, over the same period. The medical records of the control group were retrospectively evaluated for potential interventions.
RESULTS: Forty patients were enrolled in each group (aged 63 ± 17 y, mean ± SD). In the study group, 250 of 271 interventions were accepted and fulfilled. In the control group, 321 potential interventions were identified. The mean length of stay of the study group was significantly lower than that of the control group (7.9 ± 7.2 days vs 10.9 ± 7.9 days, respectively; p = 0.008). In the study group and the control group, the total interventions were related to prescribing errors (51.3% vs 45.4%), preventable adverse drug events (32.9% vs 42.3%), patient monitoring (14% vs 7%), and drug interactions (1.8% vs 5.3%). In the study group, the net drug-related cost savings totaled $2087.
CONCLUSIONS: Our study demonstrates the positive impact of a pharmacy resident on reducing the hospital length of stay and producing drug-related cost savings. Most interventions prevented adverse drug events and prescribing errors.
Key Words: impact, interventions, medical rounds, pharmacy resident
Published Online, April 17, 2007. www.theannals.com, DOI 10.1345/aph.1H603
This article has been cited by other articles:
|
|
 |
|
  B. Maack, D. R Miller, T. Johnson, and M. Dewey Economic Impact of a Pharmacy Resident in an Assisted Living Facility-Based Medication Therapy Management Program Ann. Pharmacother., November 1, 2008; 42(11): 1613 - 1620. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
